Newcastle University
Toggle Main Menu
Toggle Search
Home
Browse
Latest
Policies
About
Home
Browse
Latest
Policies
About
ePrints
Browse by author
Browsing publications by
Dr Sarah Fordham.
Newcastle Authors
Title
Year
Full text
Dr Ricky Tirtakusuma
Dr Katarzyna Szoltysek
Professor Vasily Grinev
Dr Sirintra Nakjang
Dr Daniel Williamson
et al.
Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia
2022
Dr Wei-Yu Lin
Dr Sarah Fordham
Dr Nicola Sunter
Dr Claire Elstob
Dr Thahira Rahman
et al.
Genome-wide association study identifies risk loci for progressive chronic lymphocytic leukemia
2021
Dr Sarah Fordham
Dr Helen Blair
Dr Claire Elstob
Professor Ruth Plummer
Dr Yvette Drew
et al.
Inhibition of ATR acutely sensitises acute myeloid leukemia cells to nucleoside analogs that target ribonucleotide reductase
2018
Dr Aiste McCormick
Gavin Cuthbert
Dr Rachel O'Donnell
Dr Brian Wilson
Huw Thomas
et al.
Functional characterisation of a novel ovarian cancer cell line, NUOC-1
2017
Dr Victoria Forster
Mohammed Nahari
Dr Natalia Martinez Soria
Amy Bradburn
Dr Sarah Fordham
et al.
The leukemia-associated RUNX1/ETO oncoprotein confers a mutator phenotype
2016
Dr Mark Wade
Dr Nicola Sunter
Dr Sarah Fordham
Anna Long
Dino Mašić
et al.
c-MYC
is a radiosensitive locus in human breast cells
2015
Fiona Middleton
Dr Miranda Patterson
Dr Claire Elstob
Dr Sarah Fordham
Dr Ashleigh Herriott
et al.
Common cancer-associated imbalances in the DNA damage response confer sensitivity to single agent ATR inhibition
2015
Dr Sarah Fordham
Mike Cole
Professor Julie Irving
Professor James Allan
Cytarabine preferentially induces mutation at specific sequences in the genome which are identifiable in relapsed acute myeloid leukaemia
2015
Dr Sarah Fordham
Mike Cole
Professor Julie Irving
Professor James Allan
Cytarabine leaves a mutational fingerprint in relapsing leukemia
2014
Dr Mohammad Moad
Dr Deepali Pal
Dr Anastasia Hepburn
Dr Stuart Williamson
Laura Wilson
et al.
A novel model of urinary tract differentiation, tissue regeneration, and disease: Reprogramming human prostate and bladder cells into induced pluripotent stem cells
2013
Dr Sarah Fordham
Dr Helen Marr
Professor James Allan
Searching for clarity in therapy-related myelodysplastic syndrome/acute myeloid leukemia prognostication
2013
Dr Sarah Fordham
Dr Victoria Forster
Professor Graham Jackson
Dr Simon Bomken
Professor James Allan
et al.
A functional variant in the core promoter of the
CD95
cell death receptor gene predicts prognosis in acute promyelocytic leukemia
2012
Dr Sarah Fordham
Emeritus Professor Keith Scott
Professor Julie Irving
Professor James Allan
Cellular Response to Cytarabine is Modulated by the DNA Mismatch Repair Pathway: Implications for Treatment of Acute Myeloid Leukemia
2010
Dr John Anderson
Dr Stephen Crosier
Lynne Overman
Dr Tryfonia Mainou-Fowler
Dr Sarah Fordham
et al.
Survivin in diffuse large B cell lymphoma: Evaluation as a prognostic marker
2005